23.99 USD
+0.01 (+0.04%)
23.99 USD
0 (0%)
Taking everything into account, ABCM scores 5 out of 10 in our fundamental rating. ABCM was compared to 531 industry peers in the Biotechnology industry. Both the profitability and the financial health of ABCM get a neutral evaluation. Nothing too spectacular is happening here. ABCM is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year ABCM was profitable.
In the past year ABCM had a positive cash flow from operations.
1.2 Ratios
ABCM has a better Return On Assets (0.64%) than 93.86% of its industry peers.
ABCM has a Return On Equity of 0.93%. This is amongst the best in the industry. ABCM outperforms 93.86% of its industry peers.
With an excellent Return On Invested Capital value of 1.98%, ABCM belongs to the best of the industry, outperforming 94.69% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ABCM is significantly below the industry average of 18.22%.
The last Return On Invested Capital (1.98%) for ABCM is well below the 3 year average (6.00%), which needs to be investigated, but indicates that ABCM had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.64% | ||
| ROE | 0.93% | ||
| ROIC | 1.98% |
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
1.3 Margins
Looking at the Profit Margin, with a value of 1.94%, ABCM belongs to the top of the industry, outperforming 94.86% of the companies in the same industry.
ABCM's Profit Margin has declined in the last couple of years.
ABCM has a better Operating Margin (8.70%) than 95.36% of its industry peers.
In the last couple of years the Operating Margin of ABCM has declined.
ABCM has a Gross Margin of 72.69%. This is amongst the best in the industry. ABCM outperforms 83.58% of its industry peers.
ABCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.7% | ||
| PM (TTM) | 1.94% | ||
| GM | 72.69% |
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ABCM is destroying value.
Compared to 1 year ago, ABCM has more shares outstanding
ABCM has a better debt/assets ratio than last year.
2.2 Solvency
ABCM has an Altman-Z score of 8.64. This indicates that ABCM is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ABCM (8.64) is better than 85.41% of its industry peers.
ABCM has a debt to FCF ratio of 19.99. This is a negative value and a sign of low solvency as ABCM would need 19.99 years to pay back of all of its debts.
The Debt to FCF ratio of ABCM (19.99) is better than 94.03% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that ABCM is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.30, ABCM is not doing good in the industry: 71.81% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 19.99 | ||
| Altman-Z | 8.64 |
ROIC/WACC0.22
WACC8.89%
2.3 Liquidity
ABCM has a Current Ratio of 1.26. This is a normal value and indicates that ABCM is financially healthy and should not expect problems in meeting its short term obligations.
ABCM has a Current ratio of 1.26. This is amonst the worse of the industry: ABCM underperforms 86.73% of its industry peers.
A Quick Ratio of 0.98 indicates that ABCM may have some problems paying its short term obligations.
ABCM has a worse Quick ratio (0.98) than 88.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 402.64% over the past year.
Measured over the past years, ABCM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.30% on average per year.
Looking at the last year, ABCM shows a quite strong growth in Revenue. The Revenue has grown by 17.70% in the last year.
Measured over the past years, ABCM shows a quite strong growth in Revenue. The Revenue has been growing by 11.64% on average per year.
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
3.2 Future
ABCM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.12% yearly.
ABCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.28% yearly.
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 44.43, which means the current valuation is very expensive for ABCM.
Based on the Price/Earnings ratio, ABCM is valued cheaper than 94.69% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.59, ABCM is valued quite expensively.
Based on the Price/Forward Earnings ratio of 49.32, the valuation of ABCM can be described as expensive.
Based on the Price/Forward Earnings ratio, ABCM is valued cheaper than 94.53% of the companies in the same industry.
ABCM is valuated expensively when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.43 | ||
| Fwd PE | 49.32 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ABCM is valued cheaply inside the industry as 94.20% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABCM indicates a rather cheap valuation: ABCM is cheaper than 93.86% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 374.67 | ||
| EV/EBITDA | 55.61 |
4.3 Compensation for Growth
ABCM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ABCM has a very decent profitability rating, which may justify a higher PE ratio.
ABCM's earnings are expected to grow with 52.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y68.04%
EPS Next 3Y52.49%
5. Dividend
5.1 Amount
No dividends for ABCM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.99
+0.01 (+0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners1.79%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.49B
Revenue(TTM)350.40M
Net Income(TTM)6.80M
Analysts80
Price Target20.23 (-15.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.43 | ||
| Fwd PE | 49.32 | ||
| P/S | 12.3 | ||
| P/FCF | 374.67 | ||
| P/OCF | 79.64 | ||
| P/B | 5.92 | ||
| P/tB | 42.37 | ||
| EV/EBITDA | 55.61 |
EPS(TTM)0.54
EY2.25%
EPS(NY)0.49
Fwd EY2.03%
FCF(TTM)0.06
FCFY0.27%
OCF(TTM)0.3
OCFY1.26%
SpS1.95
BVpS4.05
TBVpS0.57
PEG (NY)0.35
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.64% | ||
| ROE | 0.93% | ||
| ROCE | 3.54% | ||
| ROIC | 1.98% | ||
| ROICexc | 2.23% | ||
| ROICexgc | 7.95% | ||
| OM | 8.7% | ||
| PM (TTM) | 1.94% | ||
| GM | 72.69% | ||
| FCFM | 3.28% |
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ROICexc(3y)7.76%
ROICexc(5y)11.54%
ROICexgc(3y)24.8%
ROICexgc(5y)47.7%
ROCE(3y)9.88%
ROCE(5y)14%
ROICexgc growth 3Y-57.08%
ROICexgc growth 5Y-37.19%
ROICexc growth 3Y-42.21%
ROICexc growth 5Y-23.94%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 19.99 | ||
| Debt/EBITDA | 2.79 | ||
| Cap/Depr | 90.64% | ||
| Cap/Sales | 12.16% | ||
| Interest Coverage | 9.53 | ||
| Cash Conversion | 69.81% | ||
| Profit Quality | 169.12% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 8.64 |
F-Score5
WACC8.89%
ROIC/WACC0.22
Cap/Depr(3y)181.11%
Cap/Depr(5y)191.67%
Cap/Sales(3y)16.16%
Cap/Sales(5y)14.67%
Profit Quality(3y)125.12%
Profit Quality(5y)105.69%
High Growth Momentum
Growth
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
EBIT growth 1Y-18.45%
EBIT growth 3Y-22.8%
EBIT growth 5Y-5.74%
EBIT Next Year197.84%
EBIT Next 3Y63.16%
EBIT Next 5Y39.34%
FCF growth 1Y-42.5%
FCF growth 3Y-17.2%
FCF growth 5Y-14.26%
OCF growth 1Y66.98%
OCF growth 3Y4.34%
OCF growth 5Y8.73%
ABCAM PLC-SPON ADR / ABCM FAQ
Can you provide the ChartMill fundamental rating for ABCAM PLC-SPON ADR?
ChartMill assigns a fundamental rating of 6 / 10 to ABCM.
What is the valuation status for ABCM stock?
ChartMill assigns a valuation rating of 7 / 10 to ABCAM PLC-SPON ADR (ABCM). This can be considered as Undervalued.
How profitable is ABCAM PLC-SPON ADR (ABCM) stock?
ABCAM PLC-SPON ADR (ABCM) has a profitability rating of 8 / 10.
What is the earnings growth outlook for ABCAM PLC-SPON ADR?
The Earnings per Share (EPS) of ABCAM PLC-SPON ADR (ABCM) is expected to grow by 125.95% in the next year.
Is the dividend of ABCAM PLC-SPON ADR sustainable?
The dividend rating of ABCAM PLC-SPON ADR (ABCM) is 0 / 10 and the dividend payout ratio is 0%.